SIM2 and benign prostatic hyperplasia: Analysis of a PCa cohort [33] concluded that the expression of SIM2 mRNA is significantly higher in PCa than in benign prostate hyperplasia, with CRPC showing a further increasing trend in the expression (Supplementary Fig. S12).